These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27657476)

  • 1. Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance.
    Palazzuoli A; Testani JM; Ruocco G; Pellegrini M; Ronco C; Nuti R
    Int J Cardiol; 2016 Dec; 224():213-219. PubMed ID: 27657476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
    De Vecchis R; Baldi C; Di Biase G
    Minerva Cardioangiol; 2016 Apr; 64(2):127-37. PubMed ID: 25423291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.
    Brisco MA; Zile MR; Hanberg JS; Wilson FP; Parikh CR; Coca SG; Tang WH; Testani JM
    J Card Fail; 2016 Oct; 22(10):753-60. PubMed ID: 27374839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF.
    Palazzuoli A; Ruocco G; Vescovo G; Valle R; Di Somma S; Nuti R
    ESC Heart Fail; 2017 Nov; 4(4):479-486. PubMed ID: 28980452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The paradox of transient worsening renal function in patients with acute heart failure: the role of B-type natriuretic peptide and diuretic response.
    Ruocco G; Nuti R; Giambelluca A; Evangelista I; De Vivo O; Daniello C; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):851-858. PubMed ID: 28704280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
    Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
    Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role of different renal function phenotypes in patients with acute heart failure.
    Palazzuoli A; Ruocco G; Pellicori P; Incampo E; Di Tommaso C; Favilli R; Evangelista I; Nuti R; Testani JM
    Int J Cardiol; 2019 Feb; 276():198-203. PubMed ID: 30503187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loop Diuretic Administration in Patients with Acute Heart Failure and Reduced Systolic Function: Effects of Different Intravenous Diuretic Doses and Diuretic Response Measurements.
    Ruocco G; Feola M; Nuti R; Luschi L; Evangelista I; Palazzuoli A
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31684094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diuretic response in acute heart failure: clinical characteristics and prognostic significance.
    Valente MA; Voors AA; Damman K; Van Veldhuisen DJ; Massie BM; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JG; Givertz MM; Bloomfield DM; Fiuzat M; Dittrich HC; Hillege HL
    Eur Heart J; 2014 May; 35(19):1284-93. PubMed ID: 24585267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.
    Matsue Y; Shiraishi A; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y
    Heart Vessels; 2016 Dec; 31(12):1980-1987. PubMed ID: 26892531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose of furosemide before admission predicts diuretic efficiency and long-term prognosis in acute heart failure.
    Blázquez-Bermejo Z; Farré N; Caravaca Perez P; Llagostera M; Morán-Fernández L; Fort A; de Juan Bagudá J; García-Cosio MD; Ruiz-Bustillo S; Delgado JF
    ESC Heart Fail; 2022 Feb; 9(1):656-666. PubMed ID: 34766460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary composition predicts diuretic efficiency of hypertonic saline solution with furosemide therapy and heart failure prognosis.
    Ando T; Okuhara Y; Orihara Y; Nishimura K; Yamamoto K; Masuyama T; Hirotani S
    Heart Vessels; 2018 Sep; 33(9):1029-1036. PubMed ID: 29556693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
    Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de las Fuentes L;
    J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
    Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
    Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
    Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
    Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.
    Giamouzis G; Butler J; Starling RC; Karayannis G; Nastas J; Parisis C; Rovithis D; Economou D; Savvatis K; Kirlidis T; Tsaknakis T; Skoularigis J; Westermann D; Tschöpe C; Triposkiadis F
    J Card Fail; 2010 Dec; 16(12):922-30. PubMed ID: 21111980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Continuous Administration of Tolvaptan on Preventing Medium-Term Worsening Renal Function and Long-Term Adverse Events in Heart Failure Patients with Chronic Kidney Disease.
    Nakano Y; Mizuno T; Niwa T; Mukai K; Wakabayashi H; Watanabe A; Ando H; Takashima H; Murotani K; Waseda K; Amano T
    Int Heart J; 2018 Jan; 59(1):105-111. PubMed ID: 29332911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
    Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
    Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.